Published in Kidney Int on February 01, 1994
Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc (2004) 1.04
Arterial hypertension in diabetes mellitus: from theory to clinical practice. Hippokratia (2008) 0.82
Renal function and hemodynamic study in obese Zucker rats. Korean J Intern Med (1995) 0.82
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease. J Diabetes Complications (2016) 0.75
Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet (1982) 6.93
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. N Engl J Med (1979) 2.87
Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care (1980) 1.92
Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med (1984) 1.90
Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ (1993) 1.58
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia (1991) 1.55
Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet (1989) 1.55
Increased glomerular permeability to albumin induced by exercise in diabetic subjects. Diabetologia (1978) 1.51
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia (1994) 1.50
Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int (1992) 1.47
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care (1997) 1.45
Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord (1999) 1.39
A man with diabetes and unexplained renal failure. Lancet (1998) 1.39
Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) (1983) 1.31
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med (1983) 1.25
Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet (1980) 1.24
Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res (2001) 1.22
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia (1995) 1.22
Genesis and evolution of diabetic nephropathy. J Clin Pathol (1981) 1.21
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia (1996) 1.21
The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med (1987) 1.19
Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Lond) (1993) 1.16
Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond) (2006) 1.13
Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest (1982) 1.13
Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ (1989) 1.13
Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int (1982) 1.07
Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes (2000) 1.07
Proteinuria in diabetes. Diabetologia (1983) 1.07
Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1988) 1.04
Microalbuminuria as prediction of nephropathy in diabetics. Lancet (1982) 1.02
Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia (1995) 1.00
Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord (2000) 0.98
Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. Diabetes Care (2000) 0.97
Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes (2000) 0.95
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia (2009) 0.95
Dietary composition and renal function in healthy subjects. Nephron (1987) 0.94
Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics. Br Med J (Clin Res Ed) (1981) 0.93
Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa. Diabetes Care (2000) 0.91
Diabetic nephropathy. Br Med Bull (1989) 0.91
Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes (1996) 0.91
Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. Am J Med (1983) 0.87
Neovascularization at the vascular pole region in diabetic glomerulopathy. Nephrol Dial Transplant (1999) 0.87
The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes. Nephron (2002) 0.87
Plasma renin activity in insulin-dependent diabetics with raised glomerular filtration rate. Clin Endocrinol (Oxf) (1984) 0.86
Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy. Diabetologia (2008) 0.86
Biosynthetic human insulin: progress and prospects. Diabetes Care (1981) 0.85
Early functional and morphological changes in diabetic nephropathy. Clin Nephrol (1979) 0.85
Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron (1984) 0.84
Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia (1993) 0.84
P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia (2003) 0.84
Plasma insulin and C-peptide after subcutaneous and intravenous administration of human insulin (recombinant DNA) and purified porcine insulin in healthy men. Diabetes Care (1987) 0.84
Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant (1997) 0.84
Proteinuria and activated T-lymphocytes in diabetic nephropathy. Diabetes (1988) 0.83
Detection of potentially reversible diabetic albuminuria. A three-drop agglutination test for urinary albumin at low concentration. Diabetes (1982) 0.83
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects. Metabolism (1980) 0.82
A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes (2000) 0.81
Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia (1996) 0.81
Glucose-induced hyperkalaemia: A hazard for diabetics? Lancet (1978) 0.81
Changes in renal function in response to protein restricted diet in type 1 (insulin-dependent) diabetic patients. Diabetologia (1987) 0.81
Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. Br Med J (Clin Res Ed) (1986) 0.80
High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia (1997) 0.80
Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) (1981) 0.80
Dietary protein and the diabetic kidney. Diabet Med (1987) 0.80
Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa. Horm Metab Res (1976) 0.78
Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255. Diabetes (2007) 0.78
ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes. Diabetes Metab Res Rev (1999) 0.78
LDL subclasses in IDDM patients: relation to diabetic nephropathy. Diabetologia (1994) 0.78
Early functional and morphologic vascular renal consequences of the diabetic state. Diabetologia (1980) 0.78
Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy. J Lab Clin Med (1993) 0.78
Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine. Acta Endocrinol (Copenh) (1977) 0.78
Premature cell ageing and evolution of diabetic nephropathy. Diabetologia (1997) 0.77
An aid to the early detection and management of diabetic nephropathy: assessment of a new point of care microalbuminuria system in the diabetic clinic. Diabet Med (2001) 0.77
Lipoprotein(a) in type 1 diabetic patients with renal disease. Diabet Med (1994) 0.77
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics. Metabolism (1980) 0.77
Cardiovascular risk in diabetic kidney disease: a model of chronic renal disease. Kidney Int Suppl (2005) 0.77
Renal functional response to protein loading in type 1 (insulin-dependent) diabetic patients on normal or high salt intake. Nephron (1997) 0.76
Diabetogenic effect of cyclosporin. Br Med J (Clin Res Ed) (1987) 0.76
The effect of fish-oil on the remission of type 1 (insulin-dependent) diabetes in newly diagnosed patients. Diabetologia (1989) 0.76
QT dispersion in microalbuminuric Type 1 diabetic patients without myocardial ischemia. J Diabetes Complications (2001) 0.76
Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabet Med (1991) 0.76
Misleading meta-analysis: a need to look beyond the headlines. Diabet Med (2007) 0.76
Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion. Diabetologia (1993) 0.76
Monitoring kidney function in diabetic nephropathy. Diabetologia (1995) 0.75
Predictive value of microalbuminuria in longstanding insulin dependent diabetes. BMJ (1993) 0.75
Selective and extremely long inhibition of prolactin release in man by 1-ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta- carbonyl)-urea-diphosphate (FCE 21336). Br J Clin Pharmacol (1987) 0.75
Severe diabetic microangiopathy with normal glucose tolerance and pituitary infarction. Br Med J (Clin Res Ed) (1983) 0.75
Does "afternoon diabetes" predict diabetes? Br Med J (1978) 0.75
Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 0.75
The kidney in diabetes: significance of the early abnormalities. Clin Endocrinol Metab (1986) 0.75
Searching for new coronary heart disease risk factors. Eur Heart J (2000) 0.75
Glycaemic control in diabetic nephropathy. Br Med J (Clin Res Ed) (1984) 0.75
The glomerular hyperfiltration of diabetes is not associated with elevated plasma levels of glucagon and growth hormone. Diabetologia (1985) 0.75
Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate. Diabet Med (1996) 0.75
Kidney size and glomerular filtration rate in Type 1 (insulin-dependent) diabetes mellitus revisited. Diabetologia (1983) 0.75